5-chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-((4-methylpiperazin-1-yl)methyl)-1H-1,2,3-triazol-1-yl)phenyl)pyrimidine-2,4-diamine (WY-135), a novel ALK inhibitor, induces cell cycle arrest and apoptosis through inhibiting ALK and its downstream pathways in Karpas299 and H2228 cells (vol 284, pg 24, 2018)

被引:1
|
作者
Han, Mengting [1 ]
Shen, Jiwei [1 ]
Wang, Lijing [1 ]
Wang, Yu [2 ]
Zhai, Xin [2 ]
Li, Yao [1 ]
Liu, Meiqiao [1 ]
Gao, Meiqi [1 ]
Li, Zengqiang [1 ]
Zuo, Daiying [1 ]
Wu, Yingliang [1 ]
机构
[1] Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R China
[2] Shenyang Pharmaceut Univ, Key Lab Struct Based Drug Design & Discovery, Minist Educ, 103 Wenhua Rd, Shenyang 110016, Peoples R China
关键词
D O I
10.1016/j.cbi.2022.109871
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页数:1
相关论文
共 9 条
  • [1] 5-chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-((4-methylpiperazin-1-yl)methyl)-1H-1,2,3-triazol-1-yl)phenyl)pyrimidine-2,4-diamine (WY-135), a novel ALK inhibitor, induces cell cycle arrest and apoptosis through inhibiting ALK and its downstream pathways in Karpas299 and H2228 cells
    Han, Mengting
    Shen, Jiwei
    Wang, Lijing
    Wang, Yu
    Zhai, Xin
    Li, Yao
    Liu, Meiqiao
    Li, Zengqiang
    Zuo, Daiying
    Wu, Yingliang
    CHEMICO-BIOLOGICAL INTERACTIONS, 2018, 284 : 24 - 31
  • [2] 1-(4-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl) amino)-3-methoxyphenyl)-3-(2-(dimethylamino)ethyl)imidazolidin-2-one (ZX-42) inhibits cell proliferation and induces apoptosis via inhibiting ALK and its downstream pathways in Karpas299 cells
    Chang, Xing
    Wang, Junfang
    Bian, Jiang
    Liu, Zi
    Guo, Ming
    Li, Zengqiang
    Wu, Yingliang
    Zhai, Xin
    Zuo, Daiying
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2022, 450
  • [3] Discovery of N-{2-Methoxy-4-14-(4-methylpiperazin-1-yl)piperidin-l-yl]phenyl}-N′-[2-(propane-2-sulfonyl)phenyl]-1,3,5-triazine-2,4-diamine (ASP3026), a Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor
    Iikubo, Kazuhiko
    Kondoh, Yutaka
    Shimada, Itsuro
    Matsuya, Takahiro
    Mori, Kenichi
    Ueno, Yoko
    Okada, Minoru
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2018, 66 (03) : 251 - 262
  • [4] 1-(4-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)-3-(2-(dimethylamino)ethyl)imidazolidin-2-one (ZX-42), a novel ALK inhibitor, induces apoptosis and protective autophagy in H2228 cells
    Wang, Lijing
    Xu, Xiaobo
    Liu, Tong
    Wang, Junfang
    Shen, Jiwei
    Guo, Ming
    Wu, Yingliang
    Zhai, Xin
    Zuo, Daiying
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2020, 72 (10) : 1370 - 1382
  • [5] Synthesis, Structure-Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) Currently in Phase 1 and Phase 2 Clinical Trials
    Marsilje, Thomas H.
    Pei, Wei
    Chen, Bei
    Lu, Wenshuo
    Uno, Tetsuo
    Jin, Yunho
    Jiang, Tao
    Kim, Sungjoon
    Li, Nanxin
    Warmuth, Markus
    Sarkisova, Yelena
    Sun, Frank
    Steffy, Auzon
    Pferdekamper, AnneMarie C.
    Li, Allen G.
    Joseph, Sean B.
    Kim, Young
    Liu, Bo
    Tuntland, Tove
    Cui, Xiaoming
    Gray, Nathanael S.
    Steensma, Ruo
    Wan, Yongqin
    Jiang, Jiqing
    Chopiuk, Greg
    Li, Jie
    Gordon, W. Perry
    Richmond, Wendy
    Johnson, Kevin
    Chang, Jonathan
    Groessl, Todd
    He, You-Qun
    Phimister, Andrew
    Aycinena, Alex
    Lee, Christian C.
    Bursulaya, Badry
    Karanewsky, Donald S.
    Seidel, H. Martin
    Harris, Jennifer L.
    Michellys, Pierre-Yves
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (14) : 5675 - 5690
  • [6] 1-(4-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)-3-(2-(dimethylamino)ethyl)imidazolidin-2-one (ZX-42), a novel ALK inhibitor, induces apoptosis and protective autophagy in H2228 cells (vol 72, pg 1370, 2020)
    Wang, Lijing
    Xu, Xiaobo
    Liu, Tong
    Wang, Junfang
    Shen, Jiwei
    Guo, Ming
    Wu, Yingliang
    Zhai, Xin
    Zuo, Daiying
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2023, 75 (05) : 718 - 718
  • [7] Discovery of N-(4-{[5-Fluoro-7-(2-methoxyethoxy)quinazolin-4-yl]amino}phenyl)-2-[4-(propan-2-yl)-1H-1,2,3-triazol-1-yl]acetamide (AZD3229), a Potent Pan-KIT Mutant Inhibitor for the Treatment of Gastrointestinal Stromal Tumors
    Kettle, Jason G.
    Anjum, Rana
    Barry, Evan
    Bhavsar, Deepa
    Brown, Crystal
    Boyd, Scott
    Campbell, Andrew
    Goldberg, Kristin
    Grondine, Michael
    Guichard, Sylvie
    Hardy, Christopher J.
    Hunt, Tom
    Jones, Rhys D. O.
    Li, Xiuwei
    Moleva, Olga
    Ogg, Derek
    Overman, Ross C.
    Packer, Martin J.
    Pearson, Stuart
    Schimpl, Marianne
    Shao, Wenlin
    Smith, Aaron
    Smith, James M.
    Stead, Darren
    Stokes, Steve
    Tucker, Michael
    Ye, Yang
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (19) : 8797 - 8810
  • [8] Synthesis, antimicrobial, insecticidal and anthelmintic activity studies of some new alkyl/aryl 6-(4-(4-(4-methyl-1H-1,2,3-triazol-1-yl)phenyl amino)phenyl)-N2,N4-bis(4-methoxyphenyl)-1,3,5-triazin-2,4-diamine carbamic acid ester derivatives
    Gautam, Nidhi
    Chourasia, O. P.
    INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 2012, 51 (07): : 1020 - 1026
  • [9] Discovery of 5 Chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a Novel Inhibitor of the Jak/Stat Pathway
    Ioannidis, Stephanos
    Lamb, Michelle L.
    Wang, Tao
    Almeida, Lynsie
    Block, Michael H.
    Davies, Audrey M.
    Peng, Bo
    Su, Mei
    Zhang, Hai-Jun
    Hoffmann, Ethan
    Rivard, Caroline
    Green, Isabelle
    Howard, Tina
    Pollard, Hannah
    Read, Jon
    Alimzhanov, Marat
    Bebernitz, Geraldine
    Bell, Kirsten
    Ye, Minwei
    Huszar, Dennis
    Zinda, Michael
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (01) : 262 - 276